subscribeSubscribe
PharmaMar says potential COVID-19 treatment shows efficacy against Omicron

PharmaMar says potential COVID-19 treatment shows efficacy against Omicron
Inti Landauro REUTERS
10 Jan 2022
Share Share
PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19

PharmaMar’s cancer drug has ‘potent preclinical efficacy’ against COVID-19
Lucy Parsons PMLIVE
29 Jan 2021
Share Share
PharmaMar plans phase III trial of cancer drug for COVID-19, shares jump

PharmaMar plans phase III trial of cancer drug for COVID-19, shares jump
Emma Pinedo REUTERS
15 Oct 2020
Share Share
Boryung , PharmaMar’s partner in South Korea, announces superior potent results

Boryung , PharmaMar’s partner in South Korea, announces superior potent results
PHARMAMAR.COM/WP-CONTENT/UPLOADS/2020/07/PR_PLITIDEPSIN_IN_VITRO_RESULTS_KOREA_OK
02 Jul 2020
Share Share
Scientists Tested 47 Existing Drugs And Found Potential New Ways to Fight Covid

Scientists Tested 47 Existing Drugs And Found Potential New Ways to Fight Covid
N. KROGAN SCIENCEALERT
04 May 2020
Share Share
PharmaMar Has Announced That the Spanish Medicines Agency Aplidin® (Plitidepsin)

PharmaMar Has Announced That the Spanish Medicines Agency Aplidin® (Plitidepsin)
YAHOO
29 Apr 2020
Share Share
PharmaMar Has Announced the Spanish Medicines Agency Has Authorized APLICOV-PC

PharmaMar Has Announced the Spanish Medicines Agency Has Authorized APLICOV-PC
PR NEWSWIRE
27 Apr 2020
Share Share
PharmaMar Signs a Commercialization & Distrib. License Agreement for Aplidin®

PharmaMar Signs a Commercialization & Distrib. License Agreement for Aplidin®
PR NEWSWIRE
11 Jun 2018
Share Share
Six medicines recommended for approval, including one orphan

Six medicines recommended for approval, including one orphan
EMA
24 Mar 2018
Share Share
Meeting highlights from the Committee for Medicinal Products Human Use (CHMP)

Meeting highlights from the Committee for Medicinal Products Human Use (CHMP)
EMA
26 Jan 2018
Share Share